Cargando…
ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation
Pulmonary fibrosis is a group of life-threatening diseases with limited therapeutic options. The involvement of cannabinoid type 1 receptors (CB(1)R) has been indicated in fibrotic diseases, but whether or not the activation of CB(1)R can be a benefit for fibrosis treatment is controversial. In this...
Autores principales: | Chen, Dongxin, Tang, Huirong, Jiang, Hongchao, Sun, Lei, Zhao, Wenjuan, Qian, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959577/ https://www.ncbi.nlm.nih.gov/pubmed/35355726 http://dx.doi.org/10.3389/fphar.2022.835979 |
Ejemplares similares
-
Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-β/Smad2/3 Pathway
por: Jiang, Jintao, et al.
Publicado: (2020) -
Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway
por: Ding, Lu, et al.
Publicado: (2022) -
GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition
por: Zhou, Xiao-Ming, et al.
Publicado: (2017) -
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
por: Yu, Xiao-Yong, et al.
Publicado: (2022) -
Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats
por: Gao, Lili, et al.
Publicado: (2015)